Hypernatremia in critically ill patients with Covid-19

Recruiting

• Conditions: Other disorders of fluid, electrolyte and acid-base balance; E87; U07.1; COVID-19, virus identified

• Registration Number: DRKS00021611
• Lead Sponsor: Ortenauklinikum, Betriebsstelle Lahr

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-05-12
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 33

Inclusion Criteria

group 1: patients with positive PCR for SARS-CoV-19 and treatment on ICU, respiratory symptoms with acute onset; bilateral diffuse infiltrates in imaging; interstitial edema, not explained by cardiac causes; paO2/FiO2 < 300 mmHg
group 2: patients with positive PCR for SARS-CoV-19 and treatment on general ward, no ventilation

Exclusion Criteria

group 1&2: PCR for SARS-Cov-2 repeatedly negative
all groups: preexisting end stage renal failure with dialysis

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
absolute numbers and dynamic of sodium levels

Secondary Outcome Measures

Name	Time	Method
classification of hypernatremia